Concepedia

Xiaoqing Shi

XS

Statistics

Publications

34

Citations

2.5K

H-Index

22

Active since

1994

Affiliations

Nanjing University of Chinese Medicine(Current)

Jiangsu Province Hospital

University of British Columbia

Kinexus Bioinformatics Corporation (Canada)

Nanjing Medical University

Xiaoqing Shi is an author at Nanjing University of Chinese Medicine specializing in life sciences, molecular biology, and pharmacology.

ORCID

Publications per year

1994–2025

34

Publications

34

Antitumor Activity of HKI-272, an Orally Active, Irreversible Inhibitor of the HER-2 Tyrosine Kinase

Sridhar K. Rabindran, Carolyn Discafani, Edward Rosfjord et al. · Cancer Research · 2004 · 638 citations · Full text

, , +13

Optimization of 6,7-Disubstituted-4-(arylamino)quinoline-3-carbonitriles as Orally Active, Irreversible Inhibitors of Human Epidermal Growth Factor Receptor-2 Kinase Activity

Hwei‐Ru Tsou, Elsebe G. Overbeek-Klumpers, William Hallett et al. · Journal of Medicinal Chemistry · 2005 · 299 citations · Full text

, , +14

Synthesis and Structure−Activity Relationships of 6,7-Disubstituted 4-Anilinoquinoline-3-carbonitriles. The Design of an Orally Active, Irreversible Inhibitor of the Tyrosine Kinase Activity of the Epidermal Growth Factor Receptor (EGFR) and the Human Epidermal Growth Factor Receptor-2 (HER-2)

Allan Wissner, Elsebe Overbeek, Marvin F. Reich et al. · Journal of Medicinal Chemistry · 2002 · 266 citations · Full text

, , +15

Generation of SO3−and OH radicals in SO32− reactions with inorganic environmental pollutants and its implications to SO32−toxicity

Xiaoqing Shi · Journal of Inorganic Biochemistry · 1994 · 169 citations

, , +16

Stress-induced Inhibition of ERK1 and ERK2 by Direct Interaction with p38 MAP Kinase

Hong Zhang, Xiaoqing Shi, Maggie Hampong et al. · Journal of Biological Chemistry · 2001 · 166 citations · Full text

, , +15

1–5 of 34